4Porter AT, Fontanesi J. Palliative irradiation for bone metastasis: a new paradigm. Int J Radiat Oncol Biol Phys, 1994, 29:1199-1200.
5Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complication in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer, 2003, 98: 1735-1744.
6Rosen LS, Gordon D, Tchekmedyian NS, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non small cell lung carcinoma and other solid tumors: a randomized phase In ,double-blind, placebo-controlled trial. Cancer, 2004, 100: 2613-2621.
7Ural AU, Avcu F, Candir M, et al. In vitro synergistic cytoreductive effects of Zoledronic acid and radiation on breast cancer cells. Breast Cancer Res, 2006, 8: R52.
8Arrington SA, Damron TA, Mann KA, et al. Concurrent administration of zoledronic acid and irradiation leads to improves bone density, biomechanical strength and microarchitecture in a mouse model of tumor-induced osteolysis. J Surg Oncol, 2008, 97: 284-290.
9Kohno N. Treatment of breast cancer with bone metastasis: bisphosphonate treatment-current and future. Int J Clin Oncol, 2005, 13: 18-23.
10Coleman RE. Emerging strategies in bone health management for the adjuvant patient. Semin Oncol, 2007, 34:S11-16.
